Published in J Med Life on January 29, 2010
Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients. J Korean Med Sci (2014) 1.25
Effect of chronic kidney disease on the expression of thiamin and folic acid transporters. Nephrol Dial Transplant (2010) 0.96
Genomic damage in endstage renal disease-contribution of uremic toxins. Toxins (Basel) (2010) 0.79
Rapid resolution liquid chromatography method development and validation for simultaneous determination of homocysteine, vitamins B(6), B(9), and B(12) in human serum. Indian J Pharmacol (2013) 0.75
Homocysteine and atherothrombosis. N Engl J Med (1998) 6.70
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA (1992) 3.96
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest (1993) 2.47
Homocysteine and vascular disease. Nat Med (1996) 2.44
Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med (2000) 1.47
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA (1999) 1.42
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation (1996) 1.19
Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb (1993) 1.15
Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation (2000) 1.00
Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation (1996) 0.95
Reversal of hyperhomocyst(e)inaemia in chronic renal failure-is folic or folinic acid the answer? Nephrol Dial Transplant (1999) 0.82
Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab (2000) 0.81
Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine. Clin Nephrol (1998) 0.80
Hyperhomocyst(e)inaemia in renal failure--what are the implications? Nephrol Dial Transplant (1996) 0.79
Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease. Nephrol Dial Transplant (2001) 0.79